Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-03

Clinical Trial Update: Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing radiofrequency ablation plus chemotherapy versus chemotherapy alone for patients with secondary liver cancer has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Metastatic Liver Cancer, Secondary Liver Cancer | Phase 4 | Status: WITHDRAWN